Home » Newsletters » BioWorld

BioWorld

May 1, 1992

View Archived Issues

COLLABORATION ON ARTHRITIS, CANCER TREATMENTS

TELIOS EXPANDS WOUND HEALER TRIALS

Glycomed To Fund R&D Program

FDA CLEARS TEST FOR BLEEDING DISORDER

FDA ASKED FOR WARNING ON NICOTINE PATCHES

JAPAN OKS USE OF ENZON DRUG

GENSIA SYSTEM RECEIVES FIRST PATENT

SECOND DAY OF STOCK REBOUND

LILLY BUYS INTO BIOJECT INJECTOR SYSTEM

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...